Sandy Chevrier

1.9k total citations
29 papers, 604 citations indexed

About

Sandy Chevrier is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Sandy Chevrier has authored 29 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Cancer Research and 11 papers in Molecular Biology. Recurrent topics in Sandy Chevrier's work include Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Genetic factors in colorectal cancer (5 papers). Sandy Chevrier is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Genetic factors in colorectal cancer (5 papers). Sandy Chevrier collaborates with scholars based in France, United States and Canada. Sandy Chevrier's co-authors include Romain Boidot, Frédérique Végran, A. Gordon Robertson, Judy M.Y. Wong, David Monchaud, Pauline Lejault, S.Y. Cindy Yang, François Ghiringhelli, Sarab Lizard‐Nacol and Laurent Arnould and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Sandy Chevrier

25 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandy Chevrier France 14 362 184 125 98 83 29 604
Jinhui Wang United States 14 355 1.0× 111 0.6× 139 1.1× 86 0.9× 48 0.6× 29 547
Xinhan Zhao China 14 427 1.2× 191 1.0× 204 1.6× 63 0.6× 121 1.5× 44 684
Sylvia Mahara Singapore 8 502 1.4× 210 1.1× 179 1.4× 47 0.5× 80 1.0× 9 658
Yvonne Li Canada 9 381 1.1× 161 0.9× 92 0.7× 50 0.5× 48 0.6× 15 525
Huijing Yin China 10 286 0.8× 142 0.8× 141 1.1× 68 0.7× 108 1.3× 16 523
Yifei Feng China 14 508 1.4× 161 0.9× 250 2.0× 80 0.8× 79 1.0× 28 664
Rongkai Xie China 11 280 0.8× 245 1.3× 171 1.4× 62 0.6× 105 1.3× 23 540
Chongkui Sun China 13 337 0.9× 192 1.0× 124 1.0× 62 0.6× 125 1.5× 16 621
Linglong Yin China 10 342 0.9× 144 0.8× 122 1.0× 85 0.9× 35 0.4× 17 469
Maria A. Voronkova United States 9 280 0.8× 119 0.6× 114 0.9× 56 0.6× 91 1.1× 15 452

Countries citing papers authored by Sandy Chevrier

Since Specialization
Citations

This map shows the geographic impact of Sandy Chevrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandy Chevrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandy Chevrier more than expected).

Fields of papers citing papers by Sandy Chevrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandy Chevrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandy Chevrier. The network helps show where Sandy Chevrier may publish in the future.

Co-authorship network of co-authors of Sandy Chevrier

This figure shows the co-authorship network connecting the top 25 collaborators of Sandy Chevrier. A scholar is included among the top collaborators of Sandy Chevrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandy Chevrier. Sandy Chevrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chevrier, Sandy, Corentin Richard, M.-L. Mille, Denis Bertrand, & Romain Boidot. (2025). Nanopore adaptive sampling accurately detects nucleotide variants and improves the characterization of large‐scale rearrangement for the diagnosis of cancer predisposition. Clinical and Translational Medicine. 15(1). e70138–e70138.
2.
Richard, Corentin, Étienne Humblin, Sandy Chevrier, et al.. (2025). The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs. Cellular and Molecular Immunology. 22(5). 541–556. 7 indexed citations
3.
Richard, Corentin, Sandy Chevrier, Aurélien Marabelle, & Romain Boidot. (2024). Abstract 7611: Circulating blood RNAseq detects activation of immune system and predicts response to immunotherapy in bladder cancer. Cancer Research. 84(6_Supplement). 7611–7611.
4.
Favier, Laure, Aurélie Lagrange, Courèche Kaderbhaï, et al.. (2023). Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type. International Journal of Molecular Sciences. 24(8). 7592–7592. 2 indexed citations
5.
Richard, Corentin, Sandy Chevrier, Sophie Lemoine, et al.. (2021). The Tumor Microenvironment Impairs Th1 IFNγ Secretion through Alternative Splicing Modifications of Irf1 Pre-mRNA. Cancer Immunology Research. 9(3). 324–336. 13 indexed citations
6.
Truntzer, Caroline, Sandy Chevrier, Laure Favier, et al.. (2021). Does large NGS panel analysed using exome tumour sequencing improve the management of advanced non-small-cell lung cancers?. Lung Cancer. 161. 98–107.
7.
Chevrier, Sandy, Françoise Beltjens, Magalie Dosset, et al.. (2019). Cleaved Caspase-3 Transcriptionally Regulates Angiogenesis-Promoting Chemotherapy Resistance. Cancer Research. 79(23). 5958–5970. 69 indexed citations
8.
Chevrier, Sandy, Isabelle Desmoulins, Laure Favier, et al.. (2019). Prediction of olaparib sensitivity for variants of unknown significance in homologous repair genes.. Journal of Clinical Oncology. 37(15_suppl). 3108–3108. 1 indexed citations
9.
Richard, Corentin, Jean-David Fumet, Sandy Chevrier, et al.. (2018). Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients. Clinical Cancer Research. 25(3). 957–966. 38 indexed citations
10.
Yang, S.Y. Cindy, Pauline Lejault, Sandy Chevrier, et al.. (2018). Transcriptome-wide identification of transient RNA G-quadruplexes in human cells. Nature Communications. 9(1). 4730–4730. 166 indexed citations
11.
Richard, Corentin, Jean-David Fumet, Sandy Chevrier, et al.. (2018). Exome analysis to reveal genomic markers associated with better efficacy of nivolumab in lung cancer patients.. Journal of Clinical Oncology. 36(15_suppl). 9044–9044. 2 indexed citations
12.
Humblin, Étienne, Marion Thibaudin, Fanny Chalmin, et al.. (2017). IRF8-dependent molecular complexes control the Th9 transcriptional program. Nature Communications. 8(1). 2085–2085. 48 indexed citations
13.
Mirjolet, Céline, Julien Boudon, Alexis Loiseau, et al.. (2017). Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model. International Journal of Nanomedicine. Volume 12. 6357–6364. 17 indexed citations
14.
Ghiringhelli, François, Corentin Richard, Sandy Chevrier, Frédérique Végran, & Romain Boidot. (2016). Efficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein. World Journal of Gastroenterology. 22(48). 10680–10680. 13 indexed citations
15.
Schmitt, E., Frédérique Végran, Sandy Chevrier, et al.. (2015). Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy. BMC Cancer. 15(1). 169–169. 5 indexed citations
16.
Chevrier, Sandy, Laurent Arnould, François Ghiringhelli, et al.. (2014). Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations. International Journal of Oncology. 45(3). 1167–1174. 21 indexed citations
17.
Végran, Frédérique, et al.. (2013). Only Missense Mutations Affecting the DNA Binding Domain of P53 Influence Outcomes in Patients with Breast Carcinoma. PLoS ONE. 8(1). e55103–e55103. 35 indexed citations
18.
Boidot, Romain, Frédérique Végran, Sandy Chevrier, et al.. (2010). The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism. Oncogene. 29(17). 2577–2584. 41 indexed citations
19.
Boidot, Romain, Frédérique Végran, Sandy Chevrier, et al.. (2008). The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas. Genes Chromosomes and Cancer. 47(4). 299–308. 40 indexed citations
20.
Hassel, Mohamed Ben, et al.. (2008). Carcinome à cellules de Merkel : prise en charge et place de la radiothérapie. Cancer/Radiothérapie. 12(5). 352–359. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinhui Wang Breakdown of academic impact, for papers by Xinhan Zhao Breakdown of academic impact, for papers by Sylvia Mahara Breakdown of academic impact, for papers by Yvonne Li Breakdown of academic impact, for papers by Huijing Yin Breakdown of academic impact, for papers by Yifei Feng Breakdown of academic impact, for papers by Rongkai Xie Breakdown of academic impact, for papers by Chongkui Sun Breakdown of academic impact, for papers by Linglong Yin Breakdown of academic impact, for papers by Maria A. Voronkova
Rankless by CCL
2026